These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 662190)

  • 41. Safety of contraceptive methods: amenorrhea.
    Hanson FW
    J Reprod Med; 1975 Oct; 15(4):153-7. PubMed ID: 1214257
    [No Abstract]   [Full Text] [Related]  

  • 42. The bromsulphthalein excretion test in women receiving pill-a-month and injection-a-month steroid contraceptives.
    Iyengar V; Adatia A; Donde UM; Virkar K
    Indian J Med Res; 1976 Feb; 64(2):175-82. PubMed ID: 1270106
    [No Abstract]   [Full Text] [Related]  

  • 43. Some practical aspects of contraception.
    Beard RJ
    Clin Obstet Gynaecol; 1979 Apr; 6(1):157-70. PubMed ID: 383347
    [No Abstract]   [Full Text] [Related]  

  • 44. Ovarian steroids and pituitary function in some experimental animals and in man.
    Attia MA
    Rev Pure Appl Pharmacol Sci; 1980; 1(4):327-41. PubMed ID: 7025117
    [No Abstract]   [Full Text] [Related]  

  • 45. Vaginal cytology in astudy of cumulative effects of an oral contraceptive: acid mucopolysaccharide and keratin as indicators for cycle stages.
    Stern E; Mickey MR
    Acta Cytol; 1970; 14(7):382-5. PubMed ID: 4249474
    [No Abstract]   [Full Text] [Related]  

  • 46. [Central and peripheral actions of an oral contraceptive with reduced oestrogen content (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1977 Apr; 89(9):311-3. PubMed ID: 855349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of oral contraceptives on the oral and vaginal mucosa].
    Klinger G; Klinger G
    Dtsch Stomatol; 1970 Sep; 20(9):664-9. PubMed ID: 5273311
    [No Abstract]   [Full Text] [Related]  

  • 48. [Syndrome due to estrogen-progestogens in a worker engaged in the production of contraceptive agents].
    Gambini G; Farina G; Arbosti G
    Med Lav; 1976; 67(2):152-7. PubMed ID: 1021708
    [No Abstract]   [Full Text] [Related]  

  • 49. The influence of hormones and HIV genital transmission in women.
    Update Natl Minor AIDS Counc; 1997 Mar; ():9-11. PubMed ID: 11367434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biological activity of estrogens combined with progestagens in contraceptive preparations].
    Chruściel TL; Dudkiewicz J; Robel A; Suska T; Jurecka L
    Acta Pol Pharm; 1988; 45(1):92-6. PubMed ID: 3421141
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cytological aspect of cervico-vaginal smears from patients treated by oral contraceptives].
    Siebert S; Jobert ME; Besançon D
    Rev Fr Gynecol Obstet; 1972; 67(8):489-504. PubMed ID: 4645506
    [No Abstract]   [Full Text] [Related]  

  • 52. Determination of progestational potency: a review.
    Swyer GI
    J R Soc Med; 1984 May; 77(5):406-9. PubMed ID: 6374142
    [No Abstract]   [Full Text] [Related]  

  • 53. [Contribution to the effect of so-called ovulation inhibitors on the cercical and vaginal epithelium].
    Boquoi E; Müller JE
    Zentralbl Gynakol; 1967 Sep; 89(36):1318-23. PubMed ID: 5593155
    [No Abstract]   [Full Text] [Related]  

  • 54. Further report on the endocrinological profile of 17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9(10)-diene-3-one (STS 557) in rodents.
    Koch M; Strecke J; Kurischko A; Oettel M
    Endokrinologie; 1982 Jun; 79(2):173-84. PubMed ID: 7128539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered plasma-lipids associated with oral contraceptive or oestrogen consumption. The Lipid Research Clinic Program.
    Wallace RB; Hoover J; Sandler D; Rifking BM; Tyroler HA
    Lancet; 1977 Jul; 2(8027):11-4. PubMed ID: 69101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antithrombin and heparin-neutralizing activity in sera of women using and not using hormonal contraceptives].
    Stepanauskas M; Weissbach-Rieger A; Schwarzenecker K; Hansche N; Egger E; Heine H
    Z Med Lab Diagn; 1979; 20(5):295-301. PubMed ID: 549319
    [No Abstract]   [Full Text] [Related]  

  • 57. The effects of hormonal contraceptives on lactation: current findings, methodological considerations, and future priorities.
    Hull VJ
    Stud Fam Plann; 1981 Apr; 12(4):134-55. PubMed ID: 6755817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Colpocytological patterns after prolonged treatment with combined estroprogestinic drugs].
    Vernotico V; Zanella B
    Minerva Ginecol; 1975 Jun; 27(6):448-56. PubMed ID: 1153121
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of progestin no. 1 (cymegesolate) on menstrual cycles and plasma levels of progesterone in rhesus monkeys].
    Yang YQ; Li SX; Gu XG
    Sheng Li Xue Bao; 1985 Aug; 37(4):368-73. PubMed ID: 3837333
    [No Abstract]   [Full Text] [Related]  

  • 60. Cytological studies in women using different types of hormonal contraceptives.
    Engineer AD; Misra JS; Tandon P
    J Indian Med Assoc; 1980 Mar; 74(5):88-91. PubMed ID: 7410860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.